source
- Opinion: The smart way to regulate the peptide boom“The FDA should pursue a structured, clinician-guided framework” on popular peptides, writes former surgeon general Jerome Adams.STAT · 22d ago↗ source
- Opinion: Stopping doctors from ordering unnecessary diagnostic tests requires a structural fix“The medical industry has spent enormous effort making more advanced tests but expended little effort learning how to use tests correctly,” writes Daniel Morgan.STAT · 22d ago↗ source
- STAT+: GOP lawmakers push Trump’s FDA to make sure clinical trials are diverseSupporters say clinical trial diversity is about making sure drugs and devices work, not about DEI.STAT · 22d ago↗ source